Clinical characteristics, treatment patterns, and persistence in individuals with type 2 diabetes initiating a glucagon-like peptide-1 receptor agonist: a retrospective analysis of the diabetes prospective follow-up registry
To examine group differences in the effect of pharmacotherapy on tinnitus, an ANOVA (or ANCOVA when controlling for a pre-treatment measure as a covariate) was employed to test this specific hypothesis
Liver Panel: Liver function tests (ALT, AST, ALP, bilirubin) to detect any rare hepatobiliary events linked to pancreatitis or gallbladder disease, which have been associated with GLP-1 agonists
FDAs Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. FDA.gov, 2025
If it is cloudy, discolored, or has floating particles in it, do not use it
Some clinical trials have shown slightly greater average reduction with tirzepatide